| A claims data-based comparison of comorbidity in individuals with and without dementia K Bauer, L Schwarzkopf, E Graessel, R Holle BMC geriatrics 14, 1-13, 2014 | 175 | 2014 |
| Predictors of institutionalization of dementia patients in mild and moderate stages: a 4-year prospective analysis K Eska, E Graessel, C Donath, L Schwarzkopf, J Lauterberg, R Holle Dementia and geriatric cognitive disorders extra 3 (1), 426-445, 2013 | 138 | 2013 |
| Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage L Schwarzkopf, P Menn, S Kunz, R Holle, J Lauterberg, P Marx, H Mehlig, ... Value in Health 14 (6), 827-835, 2011 | 126 | 2011 |
| Excess costs of dementia disorders and the role of age and gender-an analysis of German health and long-term care insurance claims data L Schwarzkopf, P Menn, R Leidl, S Wunder, H Mehlig, P Marx, E Graessel, ... BMC health services research 12 (1), 1-12, 2012 | 90 | 2012 |
| Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older population M Hunger, L Schwarzkopf, M Heier, A Peters, R Holle, KORA Study Group BMC health services research 13, 1-11, 2013 | 82 | 2013 |
| Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases–a claims data analysis L Schwarzkopf, S Witt, J Waelscher, M Polke, M Kreuter Respiratory Research 19, 1-15, 2018 | 58 | 2018 |
| Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data L Schwarzkopf, P Menn, R Leidl, E Graessel, R Holle BMC health services research 13 (1), 1-11, 2013 | 56 | 2013 |
| Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens L Schwarzkopf, M Wacker, R Holle, R Leidl, C Günster, JB Adler, ... Lung cancer 90 (2), 274-280, 2015 | 48 | 2015 |
| Quality of life assessment in interstitial lung diseases: a comparison of the disease-specific K-BILD with the generic EQ-5D-5L BL Szentes, M Kreuter, T Bahmer, SS Birring, M Claussen, J Waelscher, ... Respiratory research 19 (1), 1-10, 2018 | 43 | 2018 |
| Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis S Witt, E Krauss, MAN Barbero, V Müller, P Bonniaud, C Vancheri, ... Respiratory research 20 (1), 1-11, 2019 | 42 | 2019 |
| Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study F Kirsch, A Schramm, L Schwarzkopf, JI Lutter, B Szentes, M Huber, ... Respiratory research 20, 1-15, 2019 | 41 | 2019 |
| Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study P Marijic, L Schwarzkopf, L Schwettmann, T Ruhnke, F Trudzinski, ... Respiratory Research 22 (1), 1-11, 2021 | 32 | 2021 |
| In-Patient Pulmonary Rehabilitation to Improve Asthma Control: A Randomized Controlled Study (EPRA, Effectiveness of Pulmonary Rehabilitation for Patients with Asthma) K Schultz, M Wittmann, R Wagner, N Lehbert, L Schwarzkopf, B Szentes, ... Deutsches Ärzteblatt International 118 (3), 23, 2021 | 31 | 2021 |
| Cost-effectiveness of a non-pharmacological treatment vs.“care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the … K Steinbeisser, L Schwarzkopf, E Graessel, H Seidl The European Journal of Health Economics 21, 825-844, 2020 | 24 | 2020 |
| “Age matters”—German claims data indicate disparities in lung cancer care between elderly and young patients J Walter, A Tufman, R Holle, L Schwarzkopf PloS one 14 (6), e0217434, 2019 | 24 | 2019 |
| Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care AL Frank, M Kreuter, L Schwarzkopf Respiratory medicine 152, 25-31, 2019 | 24 | 2019 |
| Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort JI Lutter, RA Jörres, K Kahnert, L Schwarzkopf, M Studnicka, S Karrasch, ... BMC pulmonary medicine 20, 1-12, 2020 | 22 | 2020 |
| The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data MB Huber, C Kurz, F Kirsch, L Schwarzkopf, A Schramm, R Leidl Respiratory research 21 (1), 1-10, 2020 | 22 | 2020 |
| Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast-track randomised controlled trial (BreathEase) M Schunk, L Le, Z Syunyaeva, B Haberland, S Tänzler, U Mansmann, ... European Respiratory Journal 58 (2), 2021 | 21 | 2021 |
| How does the EQ-5D-5L perform in asthma patients compared with an asthma-specific quality of life questionnaire? BL Szentes, K Schultz, D Nowak, M Schuler, L Schwarzkopf BMC pulmonary medicine 20, 1-11, 2020 | 20 | 2020 |
